These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25223735)

  • 101. Tumor initiation in human malignant melanoma and potential cancer therapies.
    Ma J; Frank MH
    Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.
    Miranda-Lorenzo I; Dorado J; Lonardo E; Alcala S; Serrano AG; Clausell-Tormos J; Cioffi M; Megias D; Zagorac S; Balic A; Hidalgo M; Erkan M; Kleeff J; Scarpa A; Sainz B; Heeschen C
    Nat Methods; 2014 Nov; 11(11):1161-9. PubMed ID: 25262208
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment.
    Tomellini E; Touil Y; Lagadec C; Julien S; Ostyn P; Ziental-Gelus N; Meignan S; Lengrand J; Adriaenssens E; Polakowska R; Le Bourhis X
    Stem Cells; 2015 Feb; 33(2):342-53. PubMed ID: 25286822
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells.
    Mukherjee N; Schwan JV; Fujita M; Norris DA; Shellman YG
    J Invest Dermatol; 2015 Sep; 135(9):2155-2161. PubMed ID: 25947358
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 107. PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma.
    Corrales E; Levit-Zerdoun E; Metzger P; Mertes R; Lehmann A; Münch J; Lemke S; Kowar S; Boerries M
    Cell Commun Signal; 2022 Nov; 20(1):187. PubMed ID: 36434616
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Low Levels of TRIM28-Interacting KRAB-ZNF Genes Associate with Cancer Stemness and Predict Poor Prognosis of Kidney Renal Clear Cell Carcinoma Patients.
    Czerwinska P; Mackiewicz AA
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638319
    [TBL] [Abstract][Full Text] [Related]  

  • 109. An Integrative Analysis of The Micro-RNAs Contributing in Stemness, Metastasis and B-Raf Pathways in Malignant Melanoma and Melanoma Stem Cell.
    Sahranavardfard P; Madjd Z; Emami Razavi AN; Ghanadan AR; Firouzi J; Khosravani P; Ghavami S; Ebrahimie E; Ebrahimi M
    Cell J; 2021 Aug; 23(3):261-272. PubMed ID: 34308569
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Obesity and Cancer Metastasis: Molecular and Translational Perspectives.
    Annett S; Moore G; Robson T
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339340
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract][Full Text] [Related]  

  • 112. CD271 is a molecular switch with divergent roles in melanoma and melanocyte development.
    Filipp FV; Li C; Boiko AD
    Sci Rep; 2019 May; 9(1):7696. PubMed ID: 31118427
    [TBL] [Abstract][Full Text] [Related]  

  • 113. An omega-3 polyunsaturated fatty acid derivative, 18-HEPE, protects against CXCR4-associated melanoma metastasis.
    Li J; Chen CY; Arita M; Kim K; Li X; Zhang H; Kang JX
    Carcinogenesis; 2018 Dec; 39(11):1380-1388. PubMed ID: 30184109
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Interplay between inflammatory tumor microenvironment and cancer stem cells.
    Zhang S; Yang X; Wang L; Zhang C
    Oncol Lett; 2018 Jul; 16(1):679-686. PubMed ID: 29963133
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line.
    Dosch J; Hadley E; Wiese C; Soderberg M; Houwman T; Ding K; Kharazova A; Collins JL; van Knippenberg B; Gregory C; Kofman A
    Cell Cycle; 2018; 17(2):174-181. PubMed ID: 29169283
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.
    Testa U; Castelli G; Pelosi E
    Med Sci (Basel); 2017 Nov; 5(4):. PubMed ID: 29156643
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A slow-cycling subpopulation of melanoma cells with highly invasive properties.
    Perego M; Maurer M; Wang JX; Shaffer S; Müller AC; Parapatics K; Li L; Hristova D; Shin S; Keeney F; Liu S; Xu X; Raj A; Jensen JK; Bennett KL; Wagner SN; Somasundaram R; Herlyn M
    Oncogene; 2018 Jan; 37(3):302-312. PubMed ID: 28925403
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The crosstalk between long non-coding RNAs and PI3K in cancer.
    Benetatos L; Voulgaris E; Vartholomatos G
    Med Oncol; 2017 Mar; 34(3):39. PubMed ID: 28176240
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
    Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
    Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.